comparemela.com

Latest Breaking News On - Presse financi - Page 3 : comparemela.com

PARIS, France, May 22th, 2023, 08:30 am CET – Pharnext SCA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 22, 2023

United statesFrance generalHugo brugiFabreguettes leibEdison groupEdison investment researchJanuary neovacsEuronext growthPresse financiPharnext sa stock exchangePress releaseIth alpha fr001400gun7

PHARNEXT: Edison Investment Research publishes updates research report on Pharnext

PARIS, France, May 22th, 2023, 08:30 am CET - Pharnext SCA (FR001400GUN7 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative

France generalUnited statesGewinn nurFabreguettes leibHugo brugiEdison investment researchEdison groupJanuary neovacsEuronext growthPresse financi

PHARNEXT: Pharnext supports the upcoming Spring Meeting of the Neuromuscular Diseases Study Group of the Spanish Society of Neurology (SEN)

PARIS, France, May 12th, 2023, 08:30 am CET - Pharnext SA ( FR001400GUN7 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative

United statesFrance generalFabreguettes leibJavier grandaNeuromuscular diseases groupSpanish society of neurologyNeurology serviceEuronext growth stock exchangeSpring meetingNeuromuscular diseases study groupSpanish societyHospital universitario central de asturiasHospital universitario de cabuePresse financiGefallene big techs

PARIS, France, May 12th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 12, 2023

United statesFrance generalJavier grandaFabreguettes leibNeurology serviceSpanish society of neurologyNeuromuscular diseases groupEuronext growth stock exchangeSpring meetingNeuromuscular diseases study groupSpanish societyHospital universitario central de asturiasHospital universitario de cabuePresse financiPharnext sa stock exchangePress release

PARIS, France, April 18th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with. | April 18, 2023

United kingdomFrance generalUnited statesFabreguettes leibUnited kingdom charityEuronext growth stock exchangeFriday aprilSaturday aprilKingdom conferencePresse financiPharnext sa stock exchangePress releaseIseases alpha fr001400bv89

vimarsana © 2020. All Rights Reserved.